These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29063073)

  • 1. The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis.
    Tian S; Lei HB; Liu YL; Chen Y; Dong WG
    Chronic Dis Transl Med; 2017 Sep; 3(3):169-175. PubMed ID: 29063073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metformin on the mortality of colorectal cancer patients with T2DM: meta-analysis of sex differences.
    Wang Y; Xiao J; Zhao Y; Du S; Du J
    Int J Colorectal Dis; 2020 May; 35(5):827-835. PubMed ID: 32100113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
    He XK; Su TT; Si JM; Sun LM
    Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
    Meng F; Song L; Wang W
    J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
    Nie Z; Zhu H; Gu M
    Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.
    Mei ZB; Zhang ZJ; Liu CY; Liu Y; Cui A; Liang ZL; Wang GH; Cui L
    PLoS One; 2014; 9(3):e91818. PubMed ID: 24647047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis.
    Cheng Y; Chen Y; Zhou C; Shen L; Tu F; Xu J; Liu C
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):73-81. PubMed ID: 31300371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
    Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mini-invasive
    Ye SP; Qiu H; Liao SJ; Ai JH; Shi J
    World J Gastroenterol; 2019 Jun; 25(22):2819-2832. PubMed ID: 31236004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
    Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
    Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
    Nie SP; Chen H; Zhuang MQ; Lu M
    Asian Pac J Cancer Prev; 2014; 15(16):6863-9. PubMed ID: 25169538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression.
    Ng CW; Jiang AA; Toh EMS; Ng CH; Ong ZH; Peng S; Tham HY; Sundar R; Chong CS; Khoo CM
    Int J Colorectal Dis; 2020 Aug; 35(8):1501-1512. PubMed ID: 32592092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin Use and Kidney Cancer Survival Outcomes: A Systematic Review and Meta-Analysis.
    Nayan M; Punjani N; Juurlink DN; Finelli A; Austin PC; Kulkarni GS; Uleryk E; Hamilton RJ
    Am J Clin Oncol; 2019 Mar; 42(3):275-284. PubMed ID: 30663998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and Clinicopathological Significance of MUC Family Members in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Li C; Zuo D; Liu T; Yin L; Li C; Wang L
    Gastroenterol Res Pract; 2019; 2019():2391670. PubMed ID: 31933627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of LGR5 in colorectal cancer: a meta-analysis.
    Chen Q; Zhang X; Li WM; Ji YQ; Cao HZ; Zheng P
    PLoS One; 2014; 9(9):e107013. PubMed ID: 25192390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of HLA-G in patients with colorectal cancer: a meta-analysis and bioinformatics analysis.
    Zhang Y; He S; Yu L; Shi C; Zhang Y; Tang S
    BMC Cancer; 2023 Oct; 23(1):1024. PubMed ID: 37875821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis.
    Wang Q; Shi M
    Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes mellitus and risk of colorectal adenoma: a meta-analysis of observational studies.
    Yu F; Guo Y; Wang H; Feng J; Jin Z; Chen Q; Liu Y; He J
    BMC Cancer; 2016 Aug; 16():642. PubMed ID: 27535548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and prostate cancer mortality: a meta-analysis.
    Stopsack KH; Ziehr DR; Rider JR; Giovannucci EL
    Cancer Causes Control; 2016 Jan; 27(1):105-13. PubMed ID: 26537119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis.
    Shuai Y; Li C; Zhou X
    Clin Transl Oncol; 2020 Sep; 22(9):1580-1590. PubMed ID: 32060719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.